Neeper-Bradley T L, Tyl R W, Fisher L C, Kubena M F, Vrbanic M A, Losco P E
Bushy Run Research Center, Union Carbide Corporation, Export, Pennsylvania 15632-8902, USA.
Fundam Appl Toxicol. 1995 Aug;27(1):121-30. doi: 10.1006/faat.1995.1115.
Previous studies have indicated that ethylene glycol (EG) is a developmental toxicant in rats and mice primarily when ingested. This study was designed to establish no-observed-effect levels (NOELs) for developmental toxicity of EG administered by gavage in both rodent species. Dams were administered EG on Gestation Days 6-15; rats were given 0, 150, 500, 1000, or 2500 mg EG/kg/day; mice were dosed with 0, 50, 150, 500, or 1500 mg EG/kg/day. In rat dams given 2500 mg EG/kg/day, water consumption was increased during treatment and body weights were reduced throughout gestation; liver and kidney weights were increased at euthanization (Gestation Day 21). Relative liver weights were also increased at 1000 mg/kg/day. Effects observed in rat fetuses at 2500 mg/kg/day included the following: hydrocephaly; gastroschisis; umbilical hernia; fused, duplicated, or missing arches, centra, and ribs; poor ossification in thoracic and lumbar regions; and reduced body weights. Reduced body weights, duplicated or missing ribs, centra, and arches, and poor ossification were also observed in rat fetuses at 1000 mg/kg/day. In mice, there was no apparent treatment-related maternal toxicity. In mouse fetuses (Gestation Day 18), effects were observed at 1500 mg/kg/day and included reduced body weights, fused ribs and arches, poor ossification in thoracic and lumbar centra, and increased occurrence of an extra 14th rib. At 500 mg/kg/day, slight reductions in fetal body weight and increased incidences of extra ribs were observed. Under conditions of these studies, NOELs for developmental toxicity were 500 mg/kg/day for rats and 150 mg/kg/day for mice, indicating that mice were more susceptible than rats to the teratogenic effects of EG.
以往研究表明,乙二醇(EG)主要在大鼠和小鼠经口摄入时是一种发育毒性物质。本研究旨在确定经灌胃给予EG对两种啮齿类动物发育毒性的未观察到有害作用水平(NOELs)。在妊娠第6至15天给母鼠灌胃EG;大鼠给予0、150、500、1000或2500 mg EG/kg/天;小鼠给予0、50、150、500或1500 mg EG/kg/天。在给予2500 mg EG/kg/天的大鼠母鼠中,治疗期间水消耗量增加,整个妊娠期体重减轻;处死时(妊娠第21天)肝脏和肾脏重量增加。在1000 mg/kg/天剂量下,相对肝脏重量也增加。在2500 mg/kg/天剂量下,观察到的大鼠胎儿效应包括:脑积水;腹裂;脐疝;椎弓、椎体和肋骨融合、重复或缺失;胸腰椎区域骨化不良;体重减轻。在1000 mg/kg/天剂量下的大鼠胎儿中也观察到体重减轻、肋骨、椎体和椎弓重复或缺失以及骨化不良。在小鼠中,未观察到明显的与治疗相关的母体毒性。在小鼠胎儿(妊娠第18天)中,在1500 mg/kg/天剂量下观察到效应,包括体重减轻、肋骨和椎弓融合、胸腰椎椎体骨化不良以及第14肋额外出现的发生率增加。在500 mg/kg/天剂量下,观察到胎儿体重略有减轻以及额外肋骨发生率增加。在这些研究条件下,大鼠发育毒性的NOELs为500 mg/kg/天,小鼠为150 mg/kg/天,表明小鼠比大鼠对EG的致畸作用更敏感。